Persistence, not resistance, is the cause of loss of isoniazid effect [1]

Journal of Infectious Diseases

Volumn 195, Issue 12, 2007, Pages 1870-1871

  Wallis, Robert S ^a   Palaci, Moises ^c   Eisenach, Kathleen ^b  

^a PPD   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; PALMITIC ACID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RIFALAZIL; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATE; DRUG EFFECT; DRUG EXPOSURE; DRUG TOLERANCE; INFECTION RESISTANCE; LETTER; LUNG TUBERCULOSIS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELAPSE;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 34249907261     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518044     Document Type: Letter

References (6)

1. Gumbo T, Louie A, Liu W, et al. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. J Infect Dis 2007; 195:194-201.
2. Wallis RS, Patil S, Cheon SH, et al. Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999; 43:2600-6.
3. Dietze R, Teixeira L, Rocha LM, et al. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis. Antimicrob Agents Chemother 2001; 45:1972-6.
4. Wallis RS, Phillips M, Johnson JL, et al. Inhibition of INH-induced expression of M. tuberculosis antigen 85 in sputum: a potential surrogate marker in TB chemotherapy trials. Antimicrob Agents Chemother 2001; 45:1302-4.
5. Johnson JL, Hadad DJ, Boom WH, et al. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006; 10:605-12.
6. Liu K, Yu J, Russell DG. pckA-deficient Mycobacterium bovis BCG shows attenuated virulence in mice and in macrophages. Microbiology 2003; 149:1829-35.